Results 21 to 30 of about 95,316 (246)

Influence of sample hemolysis on ELISA test results in blood screening laboratory

Zhongguo shuxue zazhi
Objective To analyze the effect of sample hemolysis on ELISA test results in blood screening laboratory, so as to determine the acceptable tolerance of hemolysis specific to laboratory test items and detection system, and provide reference for the ...
Qianqian QIN, Hongwei GE, Jing ZHANG, Zifu ZHAO, Chan LENG, Rui WANG   +5 more
doaj   +1 more source

Antiviral Immune Hemolysis

Experimental Biology and Medicine, 1973
SummaryNewcastle and parainfluenza I viruses when incubated with mouse or chick embryo erythrocytes at low multiplicity sensitized the red cells to hemolysis by antiviral antibody and complement. Two strains of influenza virus showed little or no sensitizing activity to influenza antibody.
M D, Eaton, J A, Heller
openaire   +2 more sources

Antibiofilm activity of a chionodracine‐derived peptide by NMR‐based metabolomics of cell‐free supernatant of Acinetobacter baumannii clinical strains

FEBS Open Bio, EarlyView.
KHS‐Cnd peptide is able to impair biofilm formation and disaggregate mature biofilms in Acinetobacter baumannii clinical isolates. Differences in extracellular metabolites reflect changes in biofilm metabolism due to KHS‐Cnd treatment. Among the differentially represented extracellular metabolites upon KHS‐Cnd treatment, the significantly altered ...
Fernando Porcelli, Enrico Landi, Francesco Maiurano, Irene Paris, Rosanna Papa, Marco Artini, Laura Selan, Stefano Borocci, Francesco Buonocore, Esther Imperlini   +9 more
wiley   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

Sitagliptin-induced hemolysis

Indian Journal of Pharmacology, 2010
Sitagliptin هو دواء جديد لنقص السكر في الدم عن طريق الفم من فئة مثبطات الببتيد الببتيد الرابع. يبدو أنه عامل جديد واعد لنقص السكر في الدم عن طريق الفم. المزايا هي عدم وجود نقص السكر في الدم عند استخدامه كعلاج أحادي ويسبب زيادة أقل في الوزن. نبلغ عن حالة انحلال دموي ناتج عن سيتاجليبتين، وهو تأثير جانبي نادر، لم يتم الإبلاغ عنه في الأدبيات.
Ragini Bekur, M R Nagaraja, KN Shivashankara, Weena Stanley   +3 more
openaire   +3 more sources

Rheumatologic Manifestations of Patients With Type B Insulin Resistance

Arthritis Care &Research, EarlyView.
Objective The objectives of this study were to identify laboratory and clinical features associated with type B insulin resistance (TBIR), a rare condition caused by autoantibodies that inhibit the insulin receptor, most frequently occurring in the setting of systemic lupus erythematosus (SLE), and to increase awareness of this rare, life‐threatening ...
S. Amara Ogbonnaya, Sandra G. Williams, Raphael A. Kirou, Marissa Lightbourne, Rebecca J. Brown   +4 more
wiley   +1 more source

Optimization of hemolytic performance of artificial heart pump based on CFD

Heliyon
Hemolytic performance is the key performance of artificial heart pumps. To reduce the damage to blood during the operation of artificial heart pumps and improve hemolysis performance, this paper investigates the influence of several key parameters of ...
Xin Liu, Chuangxin Huang, Yuzhong Sheng, Qi Chen, Qiuliang Wang   +4 more
doaj   +1 more source

Host‐Directed Biomaterials for Combatting Bloodstream Infections: From Macrocyclic Peptides to Immune‐Activating Cell Backpacks

Advanced Functional Materials, EarlyView.
Bloodstream infections (BSI) are one of the leading causes of mortality and morbidity in both civilian and military populations. This paper summarizes recent progress in novel treatment strategies to manage BSI arising from both bacterial and fungal pathogens using molecules, particles, and materials to elicit host‐directed immunity.
Thomas Thomou, Jagadish Krishnappa, Justin B. Schaal, Prasad Tongaonkar, Dat Q. Tran, Wenchao Gu, Yung‐Fu Chang, Michael E. Selsted, Shaoyi Jiang, Samir Mitragotri, Michael Super, Christopher J. Bettinger   +11 more
wiley   +1 more source

Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon

Brazilian Journal of Infectious Diseases, 2010
This report describes the development of hemolysis in eighteen glucose-6-phosphate dehydrogenase deficient patients treated for Plasmodium vivax malaria with chloroquine and primaquine.
Wilson M. Ramos Júnior, José F.J. Sardinha, Mônica R.F. Costa, Marli S. Santana, Maria G.C. Alecrim, Marcus V.G. Lacerda   +5 more
doaj   +1 more source

Shape‐Morphing Nanoengineered Hydrogel Ribbons as Hemostats

Advanced Functional Materials, EarlyView.
This study introduces a self‐assembling, shape‐morphing nanoengineered hydrogel ribbon system that rapidly forms porous aggregates in situ for efficient hemostasis in trauma and surgical applications. Abstract Rapid and effective hemorrhage control remains a major challenge in trauma and surgical care, particularly for complex or noncompressible wounds.
Ryan Davis Jr, Saptarshi Biswas, Jacob Aragon, Asaf Dana, Jasmine Sureka, Vaaridhi Ramanuja, Jeevika Thazhaiselvam, Sarah E. Miller, Taylor H. Ware, Akhilesh K. Gaharwar   +9 more
wiley   +1 more source